20260730_SCPI_Pemanggilan RUPS_32116108_lamp1.pdf

PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
www.organon.com




        7.     Kuorum Kehadiran dan Pengambilan Keputusan: disyaratkan kehadiran lebih dari ½ (satu per dua) bagian
               dari jumlah seluruh saham dengan hak suara, dan keputusan sah jika disetujui oleh lebih dari ½ (satu per
               dua) bagian dari seluruh saham dengan hak suara yang hadir dalam RUPS .
        8.     Sesuai dengan ketentuan dalam Pasal 18 POJK No. 15/2020, bahan mata acara Rapat tersedia sejak
               tanggal Pemanggilan Rapat sampai dengan penyelenggaraan Rapat yang dapat diakses dan diunduh
               melalui situs web Perseroan (https://www.organon.com/indonesia/).


                                                                Jakarta, 30 Juli 2026
                                                          PT Organon Pharma Indonesia Tbk
                                                                      Direksi

PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
www.organon.com




                                                     INVITATION
                                 THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
                                          PT ORGANON PHARMA INDONESIA Tbk


  The Board of Directors of PT ORGANON PHARMA INDONESIA Tbk (“the Company”), domiciled in South Jakarta,
  hereby invites the Company’s shareholders to attend the Extraordinary General Meeting of Shareholders (hereinafter
  referred to as “the Meeting”) to be held by the Company on:

               Day/Date                  : Thursday, 20 August 2026
               Time                      : 14.00 WIB - finished
               Place                     : Sinarmas MSIG Tower, 37th Floor Unit 102 & 106 Jl. Jend. Sudirman Kav. 21
                                         Setiabudi, Jakarta Selatan, DKI Jakarta

  Meeting Agenda and Explanation of Meeting Agenda:
     1. Approval of Changes to the Company’s Board of Directors, including:
         a. approval of the resignation of members of the Company’s Board of Directors and the granting of full
             release and discharge (acquit et decharge) from liability for management actions already taken;
         b. approval of the composition of the Company’s Board of Directors effective as of the close of the
             Meeting; and
         c. granting full authority and power of attorney, with the right of substitution, to the Company’s Board of
             Directors and/or designated parties to take all necessary actions in connection with such changes to
             the Company’s Board of Directors, including but not limited to recording the Meeting’s resolutions in a
             notarial deed and registering them with the competent authorities.

  Notes
      1.       The Company does not send separate invitations to its shareholders. Pursuant to Article 52(1) of Financial
               Services Authority Regulation No. 15/POJK.04/2020 concerning the Planning and Conduct of General
               Meetings of Shareholders of Public Companies (“POJK No. 15/2020”), this notice serves as the official
               invitation to the Company’s shareholders. This notice is also available on the Company’s website
               (https://www.organon.com/indonesia/).
        2.     Pursuant to Article 7(7) of the Company’s Articles of Association, those entitled to vote at the Meeting are
               the Company’s Shareholders whose names are recorded in the Company’s Shareholder Register (“DPS”)
               or who hold a securities account balance in the KSEI Collective Custody as of Wednesday, July 29, 2026,
               at 4:00 PM WIB.
        3.     For shareholders whose shares are held in KSEI’s collective custody, the Written Confirmation for the
               Meeting (“KTUR”) may be obtained from the securities firm or the custodian bank where the shareholder
               has opened their securities account.
        4.     Shareholders who are unable to attend may be represented by their proxy via e-proxy as described above
               and/or represented by their proxy at the Meeting by presenting a Power of Attorney, provided that members
               of the Board of Directors, members of the Board of Commissioners, and employees of the Company may
               act as proxies for the Company’s shareholders at this Meeting; however, the votes they cast will not be
               counted in the voting. The Power of Attorney form may be obtained during business hours at the Company’s
               Securities Administration Office (“BAE”), PT Ficomindo Buana Registrar, Jalan Kyai Caringin No. 2-A RT
               11/RW 4, Cideng, Gambir, Central Jakarta 10150, telephone number (021) 22638327, 22639048, and via
               email at ficomindo_br@yahoo.co.id (“BAE”).
        5.     Shareholders or their proxies who will attend the Meeting are requested to bring and submit a photocopy
               of a valid Identity Card or other valid identification to the registration officer before entering the Meeting
               room.
        6.     Shareholders of the Company that are legal entities, such as limited liability companies, foundations, or
               pension funds, are requested to bring complete photocopies of their Articles of Association and the most
               recent list of officers.The power of attorney form and the Independent Shareholder’s statement can be
               obtained and downloaded from the Company’s website at https://www.organon.com/indonesia/ or at the
               BAE Office. These documents must be signed and stamped with a revenue stamp. If the power of attorney
               and the Independent Shareholder Declaration are signed outside the territory of the Republic of Indonesia,

PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
www.organon.com




               they must be legalized by a local notary public and the official representative office of the Government of
               the Republic of Indonesia in that country, or an Apostille must be obtained in accordance with applicable
               regulations.
        7.     Quorum and Decision-Making: the presence of more than ½ (one-half) of the total number of shares with
               voting rights is required, and a decision is valid if approved by more than ½ (one-half) of the total shares
               with voting rights present at the General Meeting of Shareholders.
        8.     In accordance with the provisions of Article 18 of POJK No. 15/2020, the agenda materials for the Meeting
               are available from the date of the Meeting Notice until the date of the Meeting and can be accessed and
               downloaded via the Company’s website (https://www.organon.com/indonesia/).


                                                                Jakarta, 30 July 2026
                                                          PT Organon Pharma Indonesia Tbk
                                                                 Board of Directors